Showing 6,701 - 6,720 results of 61,189 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 1.38s Refine Results
  1. 6701
  2. 6702
  3. 6703

    Improved Cell-Free RNA and Protein Synthesis System by Jun Li (6494)

    Published 2014
    “…In this study, using firefly luciferase synthesis as a reporter system, we improved PURE system productivity up to 5 fold by adding or adjusting a variety of factors that affect transcription and translation, including Elongation factors (EF-Ts, EF-Tu, EF-G, and EF4), ribosome recycling factor (RRF), release factors (RF1, RF2, RF3), chaperones (GroEL/ES), BSA and tRNAs. …”
  4. 6704
  5. 6705

    Schematic representation of workflow. by Muhammad Bilal Azmi (14519913)

    Published 2023
    “…<div><p>Prematurity is the foremost cause of death in children under 5 years of age. Genetics contributes to 25–40% of all preterm births (PTB) yet we still need to identify specific targets for intervention based on genetic pathways. …”
  6. 6706

    The changes of EFR3A expression in the organ of Corti in the animals treated with kanamycin and furosemide by western blotting. by Chen Nie (686387)

    Published 2015
    “…<p>TUJ1 protein, with a molecular weight of 50 KD, was identified as an internal reference. …”
  7. 6707

    Discovery of the Diphenyl 6‑Oxo-1,6-dihydropyridazine-3-carboxylate/carboxamide Analogue J27 for the Treatment of Acute Lung Injury and Sepsis by Targeting JNK2 and Inhibiting the... by Jing Liao (193197)

    Published 2023
    “…The optimal compound <b>J27</b> decreased the release of TNF-α and IL-6 in mouse and human cells J774A.1 and THP-1 (IL-6 IC<sub>50</sub> = 0.22 μM) through the NF-κB/MAPK pathway. …”
  8. 6708

    Discovery of the Diphenyl 6‑Oxo-1,6-dihydropyridazine-3-carboxylate/carboxamide Analogue J27 for the Treatment of Acute Lung Injury and Sepsis by Targeting JNK2 and Inhibiting the... by Jing Liao (193197)

    Published 2023
    “…The optimal compound <b>J27</b> decreased the release of TNF-α and IL-6 in mouse and human cells J774A.1 and THP-1 (IL-6 IC<sub>50</sub> = 0.22 μM) through the NF-κB/MAPK pathway. …”
  9. 6709

    Table_5_UCA1 executes an oncogenic role in pancreatic cancer by regulating miR-582-5p/BRCC3.xlsx by Xiaole Hu (3335241)

    Published 2023
    “…Furthermore, we demonstrated that UCA1 positively regulated the expression of BRCC3 by inhibiting miR-582-5p. …”
  10. 6710

    DataSheet_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.zip by Xiao-yang Gong (13103400)

    Published 2022
    “…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  11. 6711
  12. 6712
  13. 6713
  14. 6714
  15. 6715
  16. 6716
  17. 6717
  18. 6718

    Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation by Bo Huang (30906)

    Published 2018
    “…Raw264.7 cells were divided into four groups: A, receiving no radiation; B, receiving no radiation + 50ngng/ml Sema3a; C, receiving 2Gy radiation; and D, receiving 2Gy radiation +50ngng/ml Sema3a. …”
  19. 6719

    LPC-DHA affects membrane phospholipid saturation. by Jia Pei Chan (5593388)

    Published 2018
    “…<p>Targeted lipidomic analysis of NSC<sup>WT</sup> and NSC<sup>KO</sup> cells treated with or without 50 μM LPC-DHA for 16 hours. (A) NSC<sup>WT</sup> cells showed increased DHA in PC, PE, and PS relative to NSC<sup>KO</sup> cells. …”
  20. 6720

    Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments by Stefania Ferro (76724)

    Published 2018
    “…The crystal structures of TyBm with inhibitor <b>3</b> (IC<sub>50</sub> value of 25.11 μM) and <b>16</b> (IC<sub>50</sub> value of 5.25 μM) were solved, confirming the binding poses hypothesized by in silico studies and revealing the main molecular determinants for the binding recognition of the inhibitors.…”